Mutual fund giant T. Rowe Price Inc. is urging Allergan Inc. to give shareholders a vote on significant acquisitions as the Botox maker hunts for potential deals amid an effort to fend off a hostile takeover by Valeant Pharmaceuticals International Inc.
from WSJ.com: US Business http://ift.tt/YlfXE9
via IFTTT
from WSJ.com: US Business http://ift.tt/YlfXE9
via IFTTT
No comments:
Post a Comment